SEARCH
= Paid-up subscribersLockyer M. Comparing cardiovascular outcomes in different diabetes drug classes. Practitioner March 2018;262(1813):8
Comparing cardiovascular outcomes in different diabetes drug classes
22 Mar 2018
Canagliflozin was associated with a lower risk of heart failure admissions compared with other classes of diabetes drugs, in a population-based retrospective cohort study from the United States.
This article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.